Clinical Trial Update: Pharmaco-economic Study of a Second Line Treatment in Advanced Non Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

This document notes completion of a Phase 3 pharmaco-economic study evaluating a second-line treatment for advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: University Hospital, Limoges | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 3 | Status: COMPLETED